With strong demographics, sustainable growth and constant technological innovation, we believe the $300 billion medical technology industry is healthcare’s most compelling investment opportunity. This thesis continued to mature in 2017, as our sector provided ongoing evidence of investor commitment, continued product development and an active funding and M&A environment.
In our report Medical Technology: Year in Review 2017, we cover:
- Public valuations: see how the medical technology sector performed compared to healthcare overall and the S&P 500
- M&A: the largest deals, the most active buyers and sectors
- Private placements: funding trends and deal characteristics
- Plus: our predictions for 2018